Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Discovery of Phthalimide-1,2,3-Triazole-N-Phenylacetamide Hybrids As Potent Α-Glucosidase Inhibitors: Design, Synthesis, Admet Prediction, and in Vitro and in Silico Enzymatic Evaluations Publisher



Gavanrudi MR1 ; Halimi M2 ; Najafzadehvarzi H3 ; Alikhani M4 ; Moazzam A5 ; Farzipour S6 ; Hosseini S7 ; Mojtabavi S8 ; Faramarzi MA8 ; Nasliesfahani E9 ; Mohammadikhanaposhtani M3 ; Mahdavi M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicinal Chemistry, Faculty of Pharmacy, Islamic Azad University, Ayatollah Amoli Branch, Amol, Iran
  2. 2. Department of Biology, Babol Branch, Islamic Azad University, Babol, Iran
  3. 3. Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  4. 4. Department of Internal Medicine, School of Medicine, Rheumatology Research Center Shariati Hospital, Tehran University of Medical Sciences, Iran
  5. 5. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
  7. 7. Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: ChemistrySelect Published:2023


Abstract

Thirteen new derivatives of the phthalimide-1,2,3-triazole-N-phenylacetamide hybrids were synthesized via simple chemical reactions. These hybrids were evaluated for their inhibitory potential against α-glucosidase in vitro and in silico. Among these thirteen derivatives, seven compounds showed excellent inhibition against studied enzyme (IC50 values=1.30−31.7 μM) as compared to positive control acarbose (IC50 value=750.1 μM) and among them, compound with 2,4-dichloro substituent on the phenyl ring of N-phenylacetamide moiety was identified as the most potent inhibitor against α-glucosidase. This compound was almost 577-fold more active than acarbose. Kinetic study on the most potent compound demonstrated that this compound is a competitive α-glucosidase inhibitor. To understand the interaction mode, stability, and flexibility of the most potent compounds, molecular docking and molecular dynamics studies were conducted. Furthermore, the drug-likeness, pharmacokinetic, and toxicity properties of the title compounds were predicted by in silico studies. © 2023 Wiley-VCH GmbH.